Published on May 14, 2021
FRIDAY, May 14, 2021 (STAT News)—After 14 long months of near-isolation, Michele Nadeem-Baker was ready for her Covid-19 vaccination. Diagnosed with chronic lymphocytic leukemia in 2012, she knew her cancer made her more vulnerable to severe illness should she become infected with Covid-19. She would leave her home in Charlestown, Mass., only to walk her chocolate lab, Gabby, with her husband, dreaming of a day when she would no longer need to keep her distance from other family and friends.
She’s fully vaccinated now, but Nadeem-Baker feels left behind by the vaccine euphoria sweeping the country as it resumes something like normal life. She has only trace amounts of antibodies to show for her two doses of Moderna’s vaccine, according to test results from a study she joined, and that puts her in limbo — uncertain how much protection she has against the virus.
The Sun Also Burns: Why Men Are at Such a Higher Risk for Skin Cancer
May 12, InsideHook
US health advisers endorse Pfizer’s COVID-19 vaccine for kids 12 and up
May 12, Chicago Tribune
The Prevent Cancer Foundation aims to provide funding for innovative projects that demonstrate potential for impact on cancer prevention/early detection. This funding can lead to future funding from other peer-reviewed sources. The grants and fellowships selection process utilizes a research proposal review system similar to that of the National Institutes of Health. The application deadline is 11:59 p.m. on July 5. Apply now.